Impel Pharmaceuticals
Beth Lydin is an accomplished accounting professional with extensive experience spanning several decades. Currently serving as Accounting Manager at Impel Pharmaceuticals since October 2017, Beth has also held the position of Senior Accountant. Prior to this, Beth worked at Oesting & Associates and Abilita, Inc. in the role of Business Manager from September 1996 to December 2017, and at RW Moss & Associates as a Business Manager. Additional experience includes interim roles as Accountant/Controller at Providence Medical Center Foundation and Business Manager/Controller at UNITEK Computer Systems. Earlier career highlights include Chief Accountant/Personnel Director at Learning World and Corporate Accounting Manager at Frederick & Nelson. Beth holds a Bachelor's degree in Accounting and Finance from Seattle Pacific University.
This person is not in any teams
Impel Pharmaceuticals
Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.